Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents 




Audio:Sep11 Sep19 Oct 17 MAP RSS Feed twitter News Now                         

Commentary

H7N9 In Shaoxing Zhejiang Has PB2 D87N
Recombinomics Commentary 21:00
October 18, 2013

State Key Laboratory of Diagnosis and Treatment of Infectious Diseases at Zhejiang University and the Zhejiang CDC have released full sequences (at GISAID) from the recent case (35M) in Shaoxing (A/Zhejiang/DTID-ZJU05/2013 and A/Zheijiang/22/2013, respectively).  Both labs used an October 14 collection, and the prompt release of sequences is commended.
 
The two sets of sequences confirmed that the lineages for all 8 gene segments matched the lineages for the consensus sequence for cases in Shanghai and adjacent provinces.  The H7 sequence by both labs was identical and included Q226L, as expected.  However, the sequences also contained Q222P, which is adjacent to the receptor binding domain.

However, the PB2 sequences differed.  A/Zhejiang/22/2013 had an avian sequence which lacked mammalian adaptation markers.  In contrast, A/Zhejiang/DTID-ZJU05/2013 had D60N and D87N.  The latter is a mammalian adaption which produces an increased polymerase activity at lower temperatures (33 C), consistent with a higher viral load in a human nose in the winter.  This temperature sensitive activity is also found in PB2 with E627K. 

The CDC sequences suggests that isolates with higher levels of D87N will more efficiently transmit human to human.

Media Link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2013 Recombinomics.  All rights reserved.